186 related articles for article (PubMed ID: 10784544)
21. Twenty-four hours of activity of cetirizine and fexofenadine in the skin.
Purohit A; Duvernelle C; Melac M; Pauli G; Frossard N
Ann Allergy Asthma Immunol; 2001 Apr; 86(4):387-92. PubMed ID: 11345280
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the safety of fexofenadine from experience gained in general practice use in England in 1997.
Craig-McFeely PM; Acharya NV; Shakir SA
Eur J Clin Pharmacol; 2001 Jul; 57(4):313-20. PubMed ID: 11549210
[TBL] [Abstract][Full Text] [Related]
23. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.
Tashiro M; Sakurada Y; Iwabuchi K; Mochizuki H; Kato M; Aoki M; Funaki Y; Itoh M; Iwata R; Wong DF; Yanai K
J Clin Pharmacol; 2004 Aug; 44(8):890-900. PubMed ID: 15286093
[TBL] [Abstract][Full Text] [Related]
24. [The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial].
Kłos K; Kruszewski J; Kruszewski R; Sułek K
Pol Merkur Lekarski; 2006 Nov; 21(125):449-53. PubMed ID: 17345838
[TBL] [Abstract][Full Text] [Related]
25. Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: duration of effect in subjects with seasonal allergic rhinitis.
Day JH; Briscoe MP; Rafeiro E; Hewlett D; Chapman D; Kramer B
Allergy Asthma Proc; 2004; 25(1):59-68. PubMed ID: 15055564
[TBL] [Abstract][Full Text] [Related]
26. Characterization of anti-inflammatory properties and evidence for no sedation liability for the novel antihistamine SUN-1334H.
Mandhane SN; Shah JH; Bahekar PC; Mehetre SV; Pawar CA; Bagad AS; Chidrewar GU; Rao CT; Rajamannar T
Int Arch Allergy Immunol; 2010; 151(1):56-69. PubMed ID: 19672097
[TBL] [Abstract][Full Text] [Related]
27. Safety of antihistamines in children.
Ten Eick AP; Blumer JL; Reed MD
Drug Saf; 2001; 24(2):119-47. PubMed ID: 11235817
[TBL] [Abstract][Full Text] [Related]
28. The systemic safety of fexofenadine HCl.
Mason J; Reynolds R; Rao N
Clin Exp Allergy; 1999 Jul; 29 Suppl 3():163-70; discussion 171-3. PubMed ID: 10444232
[TBL] [Abstract][Full Text] [Related]
29. Impact of interventions designed to increase market share and prescribing of fexofenadine at HMOs.
Benedetto SR; Sloan AS; Duncan BS
Am J Health Syst Pharm; 2000 Oct; 57(19):1778-85. PubMed ID: 11030030
[TBL] [Abstract][Full Text] [Related]
30. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
Bachert C
Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
[TBL] [Abstract][Full Text] [Related]
31. Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis.
Hampel F; Ratner P; Mansfield L; Meeves S; Liao Y; Georges G
Ann Allergy Asthma Immunol; 2003 Oct; 91(4):354-61. PubMed ID: 14582814
[TBL] [Abstract][Full Text] [Related]
32. Loratadine versus cetirizine: assessment of somnolence and motivation during the workday.
Salmun LM; Gates D; Scharf M; Greiding L; Ramon F; Heithoff K
Clin Ther; 2000 May; 22(5):573-82. PubMed ID: 10868555
[TBL] [Abstract][Full Text] [Related]
33. Effects of acrivastine and terfenadine on skin reactivity to histamine.
Leynadier F; Murrieta M; Dry J; Colin JN; Gillotin C; Steru D
Ann Allergy; 1994 Jun; 72(6):520-4. PubMed ID: 7911286
[TBL] [Abstract][Full Text] [Related]
34. [Inhibition of histamine-induced wheel after a recommended single dose administration of 10 mg cetirizine, 5 mg desloratadine, 120 i 180 mg fexofenadine, 5 mg levocetirizine and 10 mg loratadine--a randomized, double-blind, placebo controlled trial].
Kruszewski J; Kłos K; Sułek K
Pol Merkur Lekarski; 2006 Nov; 21(125):443-8. PubMed ID: 17345837
[TBL] [Abstract][Full Text] [Related]
35. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
Grant JA; Riethuisen JM; Moulaert B; DeVos C
Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924
[TBL] [Abstract][Full Text] [Related]
36. Suppression of the histamine-induced wheal and flare response by fexofenadine HCl 60 mg twice daily, loratadine 10 mg once daily and placebo in healthy Japanese volunteers.
Boyle J; Ridout F; Meadows R; Johnsen S; Hindmarch I
Curr Med Res Opin; 2005 Sep; 21(9):1495-503. PubMed ID: 16197669
[TBL] [Abstract][Full Text] [Related]
37. Multiple H1-antihistamine-induced urticaria.
Inomata N; Tatewaki S; Ikezawa Z
J Dermatol; 2009 Apr; 36(4):224-7. PubMed ID: 19348661
[TBL] [Abstract][Full Text] [Related]
38. The use of antihistamines in safety-critical jobs: a meeting report.
Mohler SR; Nicholson A; Harvey P; Miura Y; Meeves SG
Curr Med Res Opin; 2002; 18(6):332-7. PubMed ID: 12442879
[TBL] [Abstract][Full Text] [Related]
39. Cetirizine and loratadine: a comparison using the ED50 in skin reactions.
Ramboer I; Bumtbacea R; Lazarescu D; Radu JR
J Int Med Res; 2000; 28(2):69-77. PubMed ID: 10898119
[TBL] [Abstract][Full Text] [Related]
40. The costs of nonsedating antihistamine therapy for allergic rhinitis in managed care: an updated analysis.
Liao E; Leahy M; Cummins G
Am J Manag Care; 2001 Oct; 7(15 Suppl):S459-68. PubMed ID: 11680261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
